Guidance

Influenza: treatment and prophylaxis using anti-viral agents

Guidance on how to manage influenza (flu) using anti-viral agents.

• From: UK Health Security Agency
• Published: 23 January 2014
• Last updated: 1 December 2021 — See all updates

Documents

Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza

Ref: UKHSA publication gateway number: GOV-10342

PDF, 608 KB, 42 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document includes information on:

• definitions
• treatment of suspected or confirmed influenza
• post-exposure prophylaxis
• use of anti-virals in pregnancy, breastfeeding, hepatic or renal dysfunction

This guidance and related documents were previously published by Public Health England.

Published 23 January 2014
Last updated 1 December 2021 + show all updates

1. 1 December 2021

   Updated version of the guidance.

2. 8 October 2019

   Removed 'Letter to clinicians prescribing antivirals: December 2018 update'.

3. 27 September 2019

   Updated 'Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza'.

4. 24 January 2019

   Updated recommendations from manufacturers on the use of 2 drugs described in the document.

5. 31 December 2018

   Added additional advice for clinicians prescribing antivirals letter.

6. 31 October 2018

   Replaced guidance on use of antiviral agents with new version.

7. 10 October 2017

   Updated PHE guidance document.

8. 25 October 2016

   Updated with 2016 to 2017 guidance.

9. 24 October 2016

   Document entitled "Antiviral prescribing when A(H1N1)pdm09 influenza virus is the dominant circulating strain Update letter, January 2016" has been removed as it was specific to last season and therefore the information contained is no longer applicable.

10. 27 January 2016

    Update letter for antiviral prescribing when A(H1N1)pdm09 influenza virus is the dominant circulating strain.

11. 1 September 2015

    Updated guidance for the 2015 to 2016 flu season.

12. 2 February 2015

    This version (5.1) updates version 5.0 (October 2014) with revised guidance on choice of antivirals in severely immunocompromised individuals.

13. 5 November 2014

    The following have been uploaded; The use of antivirals for the treatment and prophylaxis of influenza: summary of guidance for healthcare professionals; Letter to clinicians regarding the use of antivirals in influenza

14. 4 November 2014

    Updated guidance.

15. 23 January 2014

    First published.